Evidence map›Paper›PMID 36549172›Full record

ArticleAsian journal of psychiatry2023

Long term neuropsychiatric consequences in COVID-19 survivors: Cognitive impairment and inflammatory underpinnings fifteen months after discharge.

Danmei He, Minlan Yuan, Wen Dang, Lin Bai, Runnan Yang, Jingyi Wang, Yao Ma, Bo Liu, Shiyu Liu, Simai Zhang and 2 more

Open access · greenAbstract read
In one paragraph

Article in Asian journal of psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Neurocognitive Impairment in Long COVID: A Systematic Review.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2025
    Pooled it
  2. Article
  3. Neurodegenerative and Cognitive Consequences of Long COVID.International journal of molecular sciences · 2026
    Review
  4. Article
  5. Olfactory Dysfunction and Cognitive Decline: Are They Related?Current allergy and asthma reports · 2025
    Review
  6. Article
  7. Review
  8. Infections withFrontiers in aging neuroscience · 2025
    Review
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Cognition and Memory after Covid-19 in a Large Community Sample.The New England journal of medicine · 2024
    Article
  14. Cognitive and mental health trajectories of COVID-19: Role of hospitalisation and long-COVID symptoms.European psychiatry : the journal of the Association of European Psychiatrists · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Danmei HeMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China.
Minlan YuanMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China. Electronic address: minlanyuan@outlook.com.
Wen DangMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China.
Lin BaiMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Runnan YangMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Jingyi WangMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Yao MaMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Bo LiuMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Shiyu LiuMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Simai ZhangWest China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China.
Xiao LiaoMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China.
Wei ZhangMental Health Center and Psychiatric Laboratory, West China Hospital of Sichuan University, Chengdu, China; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu, China; Med-X Center for Informatics, Sichuan University, Chengdu, China; Huaxi Brain Research Center, West China Hospital of Sichuan University, Chengdu, China. Electronic address: weizhanghx@163.com.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEmerging evidence shows that cognitive dysfunction may occur following coronavirus disease 19 (COVID-19) infection which is one of the most common symptoms reported in researches of "Long COVID". Several inflammatory markers are known to be elevated in COVID-19 survivors and the relationship between long-term inflammation changes and cognitive function remains unknown.

methodsWe assessed cognitive function and neuropsychiatric symptoms of 66 COVID-19 survivors and 79 healthy controls (HCs) matched with sex, age, and education level using a digital, gamified cognitive function evaluation tool and questionnaires at 15 months after discharge. Venous blood samples were collected to measure cytokine levels. We performed correlation analyses and multiple linear regression analysis to identify the factors potentially related to cognitive function.

resultsThe COVID-19 survivors performed less well on the Trails (p = 0.047) than the HCs, but most of them did not report subjective neuropsychiatric symptoms. Intensive care unit experience (β = -2.247, p < 0.0001) and self-perceived disease severity (β = -1.522, p = 0.007) were positively correlated, whereas years of education (β = 0.098, p = 0.013) was negatively associated with the performance on the Trails. Moreover, the abnormally elevated TNF-α levels (r = -0.19, p = 0.040) were negatively correlated with performance on the Trails in COVID-19 group.

conclusionOur findings suggest that COVID-19 survivors show long-term cognitive impairment in executive function, even at 15 months after discharge. Serum TNF-α levels may be an underlying mechanism of long-term cognitive impairment in patients recovering from COVID-19.

Indexed as

Cognitive DysfunctionCOVID-19BiomarkersHumansPatient DischargeSurvivorsTumor Necrosis Factor-alphaBiomarkersTumor Necrosis Factor-alphaCognitive functionCOVID-19Long-COVIDSystematic inflammation

Identifiers

PMID36549172
PMCPMC9751007
OpenAlexW4311513110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.